The Donor Selection & Cell Source Summit is your ultimate platform to explore the latest global regulatory requirements and differences on donor testing, understand the novel genome sequencing data being used to inform donor selection, and forge new partnerships to ease logistical coordination with donation sites to ensure exclusive availability of selected donor pools. Join Senti Biosciences, […]

CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval, a mounting wave of innovative technology developments and therapeutic applications are leading to a paradigm shift in our global healthcare systems. To this end, the 4th Annual CRISPR 2.0 Congress is your definitive […]

The Advanced Purification for Complex Biologics Summit is the first and only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines. This in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and […]

The 3rd ADC Target Selection Summit (December 5-7 | Boston, MA). This is the ultimate cover-to-cover conference providing insights to help you optimize the pairing of target, antibody, and linker-payload and develop the next generation of clinically successful ADCs beyond HER2 and TROP2. See the full program here. As the number of new clinical ADC […]

Enzyme Engineering Enabling Scalable Industrial Biotransformation for Sustainable API Production In 2023, an era of advanced enzyme engineering technology is rapidly enabling the generation of game-changing enzymes for novel transformations. As witnessed for Merck’s Islatravir and BMS’ ERED/KRED biocatalytic cascade recognition, industries are fast transitioning towards biocatalysis to capitalize on more sustainable means of synthesis. The 3rd Applied Biocatalysis Summit […]

Bringing the covalency field under one roof for the first time, the inaugural Covalent Drug Discovery Summit comes to Boston this December – gathering 80+ covalent drug specialists from the likes of Amgen, Revolution Medicines, Novartis, Totus Medicines, Covant Therapeutics and more. This is a unique opportunity to network with an audience of CXOs, VPs, Directors and […]

200+ Attendees | 33+ World-Class Speakers | 23+ Data Driven Case Studies Returning to Boston this December for its 6th year, the RNA-Targeted Drug Discovery & Development Summit is the only industry-dedicated forum solely focused on small molecules targeting RNA, with a core focus on improving selectivity and specificity to enable safe and effective drugs into […]

The Health Economics & Outcomes Research Summit is a focused intimate gathering of HEOR professionals, moving past basic introductions to advanced tactical and strategic conversations best leveraging innovative methods to demonstrate the value proposition of new drugs to secure formulary and market access. Hear cutting-edge case studies into evidence generation, modeling and real-world evidence across oncology, […]

Following recent struggles in the industry, the leading annual 8th Oncolytic Virotherapy Summit returns to Boston, MA in December (12-14), as the industry’s definitive, and most comprehensive forum. Bringing you 29+ world-class speakers, 10+ hours of networking, 2-panel discussions, 1 pre-conference focus day & more. This event will be showcasing brand-new pivotal data to ensure a pathway […]

The inaugural Gene Therapy Process Development Summit is a must-attend to discover the latest insights to bridge the gap between R&D and process development, ensuring that high-quality gene therapies are manufactured repeatably, at scale, and in a cost-effective manner. Join us in Philadelphia to discover and learn the latest insights through case study presentations, informative […]

SAE Media Group's 16th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January 2024 to unite leaders from the industry and bring you the latest advances in the combination product drug delivery space. Year on year, the field of injectable drug delivery has witnessed remarkable progress, marked by advancements in […]

With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval, investment is pouring into developing gene therapies and the role of regulatory affairs has never been more important. As the first ever regulatory affairs forum wholly dedicated to gene therapy, this […]

250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of Content The 3rd mRNA-Based Therapeutics Summit Europe returns to Berlin this 23rd-25th January to unite European biopharma, to hear from the likes of BioNTech, CureVac, Moderna, Pfizer, Ethris, Sanofi, and regulatory insights for the MHRA and EMA. Download the full brochure here: https://ter.li/1329up This is your opportunity […]

The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers, biochemists, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration. Join 23+ expert […]

As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we aim to deliver clinical results and ensure therapeutic microbiome approval in Europe. No matter what stage of development you're focusing on, this is your one-stop […]

As we witness a surge in later-stage clinical trials within the gene therapy industry, the spotlight on comparability has never been brighter. That's why we're thrilled to announce the return of the 4th Gene Therapy Comparability Summit, taking place in Boston, MA, February 13-15. This event is your gateway to uncovering how to implement effective comparability […]

100+ Technical mRNA Specialists | 35+ Expert Speakers As access to faster and higher-throughput analytical methods becomes increasingly vital, it is critical that we employ superior analytical approaches for mRNA-based therapeutics and vaccines to ensure high quality and effective drugs are approved, whilst adhering to regulatory guidelines. The 3rd mRNA Analytical Development Summit returns to Boston in February to […]

The 6th Annual CRISPR AgBio Congress is back on February 20-22, 2024 (Raleigh, NC). The dedicated congress that unites industry stakeholders across Agbiotech, big seed, distributors, and investors, to assess this new regulatory terrain, examine recent scientific breakthroughs, and strategize the journey of CRISPR products from editing to delivery, field to shelf. Discover the full […]

Viral Vector Process Development & Manufacturing Summit Create Qualitative, Accessible Treatments for Patients Following Ring Therapeutics’ injection of $86.5m to enhance novel viral vector capabilities, and BMS’s viral vector facility coming online, the viral vector market is forecasted to reach $12.8bn – not only in cell and gene therapies but also viral-vector-based vaccines and immunotherapies. […]

From Bristol Myers Squibb expanding their cardiovascular partnership with Avidity Biosciences' antibody-oligonucleotide conjugate technology, to Nurix and Seagen collaborating on a targeted protein degradation conjugate, there is now a staggering amount of investment and collaboration in the novel conjugates space. As highlighted above, drug developers are pushing the boundaries of traditional ADCs by designing and developing novel targeting formats and payloads. Whilst the likes of VincerX Pharma, Dyne Therapeuitcs and Alnylam are now […]

Cell therapy continues to transform the oncology field, and this year has also seen the translation of cell therapies’ curative potential into the autoimmune space. Providing your team with exclusive access to cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe is your must-attend forum to stay at the forefront of these innovations.   300+ […]

The Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Actively engage with the likes of Merck, Pfizer, SNIPR Biome, Locus Biosciences, Phiogen, AMR Action Fund and 90+ phage experts to demonstrate positive clinical data and patient outcomes. Take advantage of this unique opportunity to be a part of the dialogue, […]

With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has skyrocketed in recent years. The DNA Process Development & Manufacturing Summit is the only industry-dedicated forum to focus on topics such as DNA construct design, sequencing technology, […]

We find ourselves at the cutting edge of oncology innovation, with the ADC field booming with excitement due to the constant eflux of clinical progress and a plethora of high-value collaborations. As such the 14th World ADC London 2024 returns this March as a crucial touchpoint for all antibody drug conjugate developers across Europe. This meeting is the place […]

Returning for the seventh year, the 7th Antigen-Specific Immune Tolerance Summit (March 18 - 20, 2024 | Boston, MA) will lean into the industry’s key challenges from details of T-cell assays in preclinical and larger clinical studies; to pioneering CAR-Treg, mRNA-LNP, biologic, peptide, approaches and updates on proof-of-concept and ongoing clinical programs. This is the highest value […]

“The translational impact and nature of the work that was being presented were outstanding. You get a lot of insights from your peers regarding their experience interacting with the regulatory agencies” – ONK Tx The 9th Innate Killer Summit is designed for experts striving to realize the clinical potential of NK–based therapies from early discovery to later stages […]

The Definitive Industry Forum for CKD Drug Development Advance More Personalized Therapies for Rare & Common Kidney Diseases The 6th CKD Drug Development Summit is the definitive forum for KOLs, industry experts, and regulators to bring kidney innovation onto the next generation of drug development, uniting 200+ biopharma stakeholders, from scientific research to clinical development […]

In the dynamic cell therapy landscape, the challenge of potency assay development looms large, as exemplified by clinical holds experienced by Mesoblast and Verve Therapeutics in recent years. At the 3rd Cell Therapy Potency Assay Summit, we bring together over 120 analytical, quality control, and regulatory experts including esteemed organizations like BMS, J&J, Atara Biotherapeutics, Fate Therapeutics, Health […]

Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise. Back in Boston as the only industry forum defining global regulations for EAP and your definitive networking opportunity to connect with managed access teams from other leading […]

The 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit is returning to Boston this upcoming March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient […]